Chemical Structure : Setipiprant
CAS No.: 866460-33-5
Catalog No.: PC-20092Not For Human Use, Lab Use Only.
Setipiprant (ACT-129968, KYTH-105) is a potent, selective and orally available CRTH2 antagonist with IC50 of 6 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
25 mg | $68 | In stock | |
50 mg | $98 | In stock | |
100 mg | $158 | In stock | |
250 mg | $258 | In stock | |
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Setipiprant (ACT-129968, KYTH-105) is a potent, selective and orally available CRTH2 antagonist with IC50 of 6 nM.
Setipiprant is selective for CRTH2/DP2 over DP1 in a radioligand binding assay (IC50=1,290 nM) and the prostaglandin E2 receptor subtypes EP2 and EP4 in a β-arrestin assay (IC50s=2,600 and >10,000 nM, respectively).
Setipiprant inhibited PGD2-induced calcium flux in HEK293 cells expressing human CRTH2/DP2 (IC50 = 30 nM) and PGD2-induced shape change in human eosinophils (IC50=235 nM).
Setipiprant reduced both the allergen-induced LAR and the associated AHR in allergic asthmatics.
M.Wt | 402.43 | |
Formula | C24H19FN2O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid |
1. Risch P, et al. J Med Chem. 2015 Oct 22;58(20):8011-35.
2. Diamant Z, et al. Clin Exp Allergy. 2014 Aug;44(8):1044-52.
3. Fretz H, et al. J Med Chem. 2013 Jun 27;56(12):4899-911.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright